右美托咪定用于子痫前期剖宫产全麻的随机双盲试验
本研究为随机双盲对照试验,纳入60例子痫前期行剖宫产全麻患者,比较右美托咪定0.4与0.6 μg/kg/h输注与生理盐水对插管血流动力学和应激激素的影响。结果显示右美托咪定组平均动脉压和心率显著低于对照组,血糖和皮质醇更低,术后镇痛需求减少,新生儿Apgar评分无差异。
要点
- 右美托咪定0.4和0.6 μg/kg/h可减轻子痫前期剖宫产全麻插管期血流动力学波动。
- 右美托咪定组血糖和皮质醇显著低于对照组,提示应激反应受抑。
- 右美托咪定延长首次镇痛时间、降低VAS评分和吗啡总用量,且不改变新生儿Apgar评分。
核心结论
- 右美托咪定0.4和0.6 μg/kg/h用于子痫前期剖宫产全麻可维持血流动力学和激素稳定,未导致显著新生儿不良结局。
研究设计与样本
- 随机双盲对照研究,单中心大学医院,纳入60例18至45岁子痫前期行剖宫产全麻患者,随机分三组。
主要发现
- 右美托咪定组各评估时点平均动脉压显著低于对照组。
- D1和D2组心率显著低于对照组,D2组心率低于D1组。
- 对照组血糖和皮质醇显著高于D1和D2组。
- D2组恢复室镇静评分显著高于D1组,D1组高于对照组。
- D2和D1组首次镇痛时间显著长于对照组,术后1、2、3、5小时VAS评分显著低于对照组,吗啡总用量显著低于对照组。
关键数值与推荐
- 右美托咪定剂量:诱导前10分钟输注1 μg/kg,随后分别以0.4 μg/kg/h(D1组)和0.6 μg/kg/h(D2组)维持。
临床怎么用
- 子痫前期剖宫产全麻时可考虑右美托咪定0.4或0.6 μg/kg/h辅助,以减轻插管应激和改善术后镇痛。
局限性
- 单中心研究,样本量60例,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: During general anaesthesia, endotracheal intubation of patients with pre-eclampsia causes stimulation of the sympathetic nervous system and catecholamine release, which may lead to maternal and neonatal complications. OBJECTIVE: To attenuate both the stress response and the haemodynamic response to tracheal intubation in patients with pre-eclampsia. DESIGN: A randomised, double-blind, controlled study. SETTING: Single University Hospital. PATIENTS: Sixty patients aged 18 to 45 years with pre-eclampsia receiving general anaesthesia for caesarean section. INTERVENTIONS: The patients were randomly allocated to three groups. Groups D1and D2 received an infusion of dexmedetomidine 1 μg kg over the 10 min before induction of general anaesthesia, then 0.4 and 0.6 μg kg h dexmedetomidine, respectively. Group C received equivalent volumes of 0.9% saline. MAIN OUTCOME MEASURES: The primary outcome was the effect of dexmedetomidine on mean arterial blood pressure measured before induction of general anaesthesia at 1 and 5 min after intubation, and then every 5 min until 10 min after extubation. The secondary outcomes were blood glucose and serum cortisol (measured before induction of general anaesthesia, and at 1 and 5 min after intubation), postoperative visual analogue pain scores, time to first request for analgesia, the total consumption of analgesia, Ramsay sedation score, maternal and placental vein blood serum levels of dexmedetomidine and neonatal Apgar score at 1 and 5 min. RESULTS: At all assessment times, the mean arterial pressures were significantly lower in the dexmedetomidine groups than in the control group. Compared with group C, the heart rate was significantly lower in both groups D1 and D2. In group D2, the heart rate was lower than in group D1. Serum glucose and cortisol were significantly higher in the controls than in either group D1 or D2. Group D2 patients were significantly more sedated on arrival in the recovery room followed by D1. Time to first analgesia was significantly longer in groups D2 and D1 than in group C, and the visual analogue pain scores were significantly lower in groups D1 and D2 than in group C at 1, 2, 3 and 5 h. Total morphine consumption was significantly lower in groups D1 and D2 than in the control group. There was no difference in Apgar scores across the three groups despite significantly higher dexmedetomidine concentrations in group D2 (both maternal and placental vein) than in group D1. CONCLUSION: Administration of dexmedetomidine in doses 0.4 and 0.6 μg kg h was associated with haemodynamic and hormonal stability, without causing significant adverse neonatal outcome. TRIAL REGISTRATION: Pan African Clinical Trial Registry (PACTR201706002303170), (www.pactr.org).
引用
- Eskandr AM, Metwally AA, Ahmed AA, et al. Dexmedetomidine as a part of general anaesthesia for caesarean delivery in patients with pre-eclampsia: A randomised double-blinded trial. Eur J Anaesthesiol. 2018. PMID: 29432379. doi:10.1097/EJA.0000000000000776
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。